MedPath

ADALAT XL PLUS

ADALAT XL PLUS

Discontinued
DIN Number

02313774

Drug Class

Human

Market Date

Jul 24, 2008

Company
HC

Bayer Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02313774
AIG Number0252472002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C08CA55 NIFEDIPINE, COMBINATIONS
Product Specifications
Dosage FormTablet (Extended-Release) ,  Tablet (Delayed-Release) ,  Kit
Route of AdministrationOral
AHFS Classification24:28.08
Health Canada Classification

ACTIVE INGREDIENTS (2)

ACETYLSALICYLIC ACIDActive
Strength: 81 MG
Monograph: ACETYLSALICYLIC ACID
NIFEDIPINEActive
Strength: 30 MG
Monograph: NIFEDIPINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.